{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Back Bay Life Science Report","title":"Vaccine Developments 2024: A Podcast Discussion on Latest Vaccine Technology and Ongoing Clinical Developments","html":"","width":"100%","height":180,"duration":2254,"description":"Guests: Pete Bak and Christian Thienel\n \nLength: 37 minutes\n \nWith the advent of COVID-19 in 2020 and 2021, we saw a tremendous amount of interest in not only COVID vaccines, but other companies riding the tailwind and developing vaccine therapies that span across viral illness, maternal infections and bacterial infections.\n \nIn this episode resident immunologist Dr. Pete Bak and Christian Thienel discuss vaccine technology, up-and-coming areas of interest, such as RSV, and the vaccines currently in late-stage clinical development.\n \nTopics in this podcast include:\n \nVaccine technology, vaccine types and their varying levels of durability\nThe ongoing interest of vaccine development for RSV, including data from GSK’s Arexvy and Pfizer’s Abrysvo vaccines\nHow recommendations from the Advisory Committee on Immunization Practices (ACIP) influence commercial dynamics\nThe interesting chess game of scheduling vaccines as they relate to COVID, flu and RSV (seasonality versus strains and antigens) \nVaccine development and data as it applies to Cytomegalovirus (CMV) and Epstein-Barr (EBV)\nNews from the bacterial front: MinervaX leading the way with a maternal vaccine against Group B streptococcus infections with a very large series B round for $54M; Pfizer’s recent Prevnar 20 against pneumococcal pneumonia\nPricing, reimbursement and the interplay with ACIP guidelines\n \nAs always, we welcome listener questions and/or topics you’d like to learn more about.\n \nYou can listen to previous episodes here or submit your inquiries here.","thumbnail_url":"https://img.transistorcdn.com/W6Lngt-BhnFN8FVt3HSPeq-NUJHgo4jaJncMb2aU6_E/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81NjE3/MTc3NDg3NzgyNTI0/ODE3Y2ViM2Q4OWI5/MDUzMC5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}